|
Adaptive Public Information Campaigns(PDF, 3MB)
This session highlights two public awareness campaigns in Colorado. The Fentanyl Awareness Campaign is a new project out of the Colorado Consortium for Prescription Drug Abuse Prevention targeting adults at 18-44 who use drugs recreationally. The other is a successful campaign that has adapted in recent years to better address stigma.
|
Michael Davidson
Colorado Consortium for Prescription Drug Abuse Prevention
Charlotte Whitney
Behavioral Health Administration
|
|
Surveillance of Fentanyl Use in Denver and Colorado from Three Different Data Perspectives(PDF, 3MB)
The RADARS® System is a drug surveillance system that collects timely, geographically specific data. RADARS has focused on opioid use and misuse as a priority clinical condition since its inception. RADARS contributes to the understanding of drug use trends, which aids the development of effective interventions. RMPDS helps public health stakeholders understand how drugs are being used by providing exposure characteristics, product identification, behaviors associated with use, outcomes, and root cause analysis of product exposures.
|
Joshua C. Black, Ph.D
Rocky Mountain Poison & Drug Safety
|
|
From Grassroots to Government: Naloxone in Colorado(PDF, 6MB)
This session covers the history of naloxone access in Denver/Colorado, from grassroots efforts by harm reduction agencies and people who use drugs, to the robust government support currently seen.
|
Lisa Raville
Harm Reduction Action Center
Jericho Dorsey
Colorado Department of Public Health and Environment
Rachael Duncan, Pharm.D., BCPS, PCCCP
Colorado Naloxone Project
|
|
Beyond Overdose: Identifying and Addressing Infections and Other Medical Complications of Fentanyl Use(PDF, 9MB)
The scope of morbidity and mortality caused by injection drug use extends well beyond overdose and includes a variety of serious bacterial, fungal, and viral infections. Recognizing the risk factors for these infections and intervening can be life-changing. Harm reduction to reduce infections goes well beyond syringe access. Treating serious medical conditions before or alongside treatment for substance use disorder is imperative in cases of acute bacterial and fungal infections, and in cases of chronic viral infections, the approach may build trust in the medical system and improve health which may in turn lead to more successful treatment for substance use disorders.
|
Sarah Rowan, MD
Denver Health
|
|
Community-based Drug Checking Technologies(PDF, 6MB)
There are many different types of drug-checking/screening technologies available nationally and internationally. With increased variability in the drug supply, new technology is essential to understanding risk and overdose prevention strategies. This session provides information on fentanyl test strips, reagent testing, and advanced technologies (such as FTIR).
|
Jessica Breemen, MSW, PSM
DanceSafe
|
|
Community Voice: Ensuring that Our Work Starts and Ends with the Communities that We Serve(PDF, 1MB)
This session details the multiple strategies that Denver Health’s Center for Addiction Medicine is using to engage and integrate community voice and share pertinent outcomes, as they relate to both community engagement and the development of responsive behavioral health initiatives. Additionally, session participants will have the opportunity to hear from several community members regarding their preferred engagement mechanisms and their perspective of the import and impact of their involvement in the CAM’s community voice activities.
|
Sarah Belstock
Public Health Institute at Denver Health
|
|
Trauma, the Brain, and Substance Use(PDF, 1MB)
Substance use does not occur in a vacuum. For many, substance use is a coping mechanism based on trauma backgrounds. Research shows why some individuals are more prone to addiction, and how effective treatment requires trauma-oriented therapy that addresses root causes of substance use and assist in building resilience and coping mechanisms.
|
Carron Maclean, MA, LPC, NCC, ACS
New Pathways Counseling
|
|
Multiple Pathways to Recovery Panel Discussion: Peer Support and Recovery Services
*No slide deck, video recording is available on the recordings tab.
This panel discussion will highlight the importance of peer support and recovery-oriented programs, including a discussion on abstinence-based vs. non-abstinence based services, the four pillars of recovery, and any potential changes to the recovery/peer support landscape following the introduction of fentanyl in Colorado.
|
Duke Rumely
Sober AF Entertainment
Emily Burks
Young People in Recovery
Darin Valdez
Colorado Artists in Recovery
Racquel Garcia NCPRSS, YRC, CAC
HardBeauty
Dominique Knowles, CPFS, Springs Recovery Connection; Springs Recovery Connection
|
|
Resources & Recovery (Previously listed as Dose of Knowledge and SKY Recovery)(PDF, 5MB)
Substance use continues to indiscriminately plague our society. Prevention and deep healing are key to addressing this widespread issue from both ends of the spectrum. Join experts in the health and well-being space to learn of tangible evidence-based programs which aim to educate, and reclaim lives impacted by substance. CVS’s Pharmacists Teach and Discovery Education have partnered to create the Dose of Knowledge® program. The program strives to empower educators and pharmacists to address substance misuse and educate students to make good decisions for the health and well-being of themselves and their community. SKY Recovery program is a holistic mind-body intervention that is designed for helping individuals and communities to recover from substance use disorders. We welcome you to take part in this informative and experiential session.
|
Dani Ottoson, Pharm.D.
CVS Health
Priya Narayanan, MD
SKY Recovery
Jim Boyman, Aetna
|
|
Caring for Pregnant and Parenting People with Opioid Use Disorder(PDF, 1MB)
This session discusses some of the special considerations for screening, assessment, and treatment options for pregnant and parenting people with opioid use disorder, including fentanyl use. Using a family-oriented, intergenerational, and strengths-based approach, we will explore how families navigating the health care, substance treatment, and potentially human services, systems can feel best supported and thrive.
|
Kaylin Klie, MD, MA
CU School of Medicine, CeDAR
|
|
Education and Awareness Panel Discussion: Communication & Resource Needs in Different Communities
*No slide deck, video recording is available on the recordings tab.
This panel discussion highlights current efforts to reach people who currently use or may use substances in different populations; the experiences, needs, and successes in different communities. In addition, we will discuss the positive and/or negative impacts of current communication strategies related to overdoses and the changing drug supply.
|
Stephanie Salazar-Rodriguez, MPH, MNM
Blazing Cloud Consulting
Chris Benjamin
Boulder County Public Health
Laura Cash, MA
GRASP
Broken No More
Terri Richardson, MD
Colorado Black Health Collaborative
Melinda Dorn, CPFS
Culinary Hospitality Outreach & Wellness (CHOW)
Alexis “Lex” Irias, Young People in Recovery
|
|
How the Center for Addiction Medicine's Model Allows Adaptation to Address the Fentanyl Crisis(PDF, 2MB)
This session shares lessons learned related to Denver Health's Center for Addiction Medicine (CAM) -an agency-wide strategic initiative to coordinate substance use treatment throughout our vast health care system. CAM implemented a hub-and-spoke model, with no wrong door, so that anywhere a patient enters the system they can be evaluated for a substance use disorder and linked into the right level of care. CAM brings together our broad range of addiction programs and medical resources into a single treatment model across Denver Health by assuring a full continuum of care that provides the patient access to an array of substance treatment services.
|
Josh Blum, MD
Jennifer Naeger, LCSW, LAC
Brooke Bender, MPH
Denver Health, Center for Addiction Medicine
|
|
Modeling Potential Implications of Colorado Fentanyl Felonization(PDF, 1MB)
On July 1, 2022, possession of small amounts of fentanyl became a felony in the state of Colorado. This session outlines a policy model that aims to understand the impacts of the new law. Specifically, the model estimates overall arrests for incidental fentanyl use and overdose mortality. In addition, the model can estimate the state-level costs of this law in terms of additional arrests and changes to overdoses rates caused by prison time. The presentation also covers an online tool that advocates, clinicians, and policy- and decision-makers can use to see the potential effects of these law within their own community, based on community drug use statistics and policies implemented.
|
Alexandra Savinkina
Yale School of Public Health
Gregg Gonsalves, MD
Yale School of Public Health
Joshua Barocas, MD
CU School of Medicine
|